Not Found
Product Type
On Demand

Total Credits: 1 AOA Category 1-A Credit(s)

Average Rating:
   4.6
Faculty:
Leonard Hock, DO, MACOI, CMD, HMDC
Short Description:
Leonard R. Hock, DO, MACOI, CMD, HMDC reviews Advanced Care Planning. He will advise on how you are able to assist/support patients in developing an Advance Care Plan (ACP). Understand ACP resistance and be able to facilitate QUALITY DECISION MAKING. Be able to use ACP to your advantage; clear choice for patient’s wishes, decrease time and anxiety of late decision making, your sense of helping the patient/family and your revenue.
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .5 AOA Category 1-A Credit(s), .5 AMA PRA Category 1 Credit(s)™

Average Rating:
   4.8
Faculty:
Robert McNab, DO, FACP, FACOI
Price:
$20.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
William Elliott, M.D. Ph.D.
Short Description:
Physicians and medical professionals will learn why long-term randomized clinical trials against placebo were done to verify the cardiovascular safety of novel hypoglycemic agents. They will compare and contrast outcomes in randomized clinical trials for sodium-glucose-linked transporter-2 inhibitors, glucagon-like peptide-1 agonists, and dipeptidyl peptidase-4 inhibitors for cardiovascular or renal endpoints. They will be able to name the pharmacological agents (and their indications) that have received FDA approval for "benefits beyond glucose-lowering" with regard to preventing cardiovascular or renal endpoints.
Price:
$30.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™

Average Rating:
   4.9
Faculty:
Joseph Carrington, DO, MHA
Short Description:
In this lecture, Dr. Carrington will define and describe coronavirus infection and COVID-19 Pathology. He will also discuss the evidence for the current recommended therapies for COVID-19. He will address the various therapies and what the most up-to-date evidence is showing for each therapy. He will conclude by discussing the current evidence regarding each of the COVID-19 vaccines.
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1.25 AOA Category 1-A Credit(s)

Average Rating:
   4.6
Faculty:
Timothy Morgan, DO
Short Description:
Stroke Madness and the Road to Endovascular Stroke Therapy
Price:
$50.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: 1 AOA Category 1-A Credit(s), 1 AMA PRA Category 1 Credit(s)™

Average Rating:
   4.2
Faculty:
Mark Baldwin, DO, FACOI, FASN
Short Description:
In this lecture, Dr. Baldwin will discuss and help physicians understand the increased risks of COVID-19 faced by minorities and rural populations. He will address the roles of the social determinants of health in the pandemic. He will also address the role of expanded Medicaid programs. He will conclude by discussing the challenges and successes in the COVID-19 vaccine rollout.
Price:
$40.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .75 AOA Category 1-A Credit(s)

Average Rating:
   4.5
Faculty:
Richard P Foellner, DO, DO
Short Description:
In this lecture, Dr. Foellner discusses ways to remove heart attacks and strokes off the top of the mortality and morbidity billboard.
Price:
$30.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .5 AOA Category 1-A Credit(s)

Average Rating:
   3.8
Faculty:
Donald Grewell, DO, FAAFP
Price:
$20.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
Logan Banks, DO, FAAFP
Short Description:
This lecture will discuss the history, value, and personal benefits of international medical services and missions.
Price:
$30.00 - Base Price

Not Found
Product Type
On Demand

Total Credits: .75 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
Faculty:
William Elliott, M.D. Ph.D.
Short Description:
Physicians and medical professionals will compare and contrast current methods of blood pressure management and explain the impact of the results of the Systolic Blood Pressure Intervention Trial (SPRINT Study) on current US Hypertension guidelines. They will be able to match the appropriate voluntary health organization (or authoritative body) with each of the 3 currently recommended blood pressure targets: <140/90 mm Hg, systolic <130 mm Hg, or systolic <120 mm Hg.
Price:
$30.00 - Base Price

Please wait ...

Back to Top